TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Kårhuset Pharmen AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 97 | 78 | 93 |
Financial expenses | 6 | 19 | 25 |
Earnings before taxes | -7 | -36 | 43 |
EBITDA | 23 | 20 | 35 |
Total assets | 971 | 972 | 1,120 |
Current assets | 100 | 80 | 95 |
Current liabilities | 24 | 21 | 47 |
Equity capital | 832 | 836 | 948 |
- share capital | 2 | 539 | 587 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 85.7% | 86.0% | 84.6% |
Turnover per employee | 97 | 78 | 93 |
Profit as a percentage of turnover | -7.2% | -46.2% | 46.2% |
Return on assets (ROA) | -0.1% | -1.7% | 6.1% |
Current ratio | 416.7% | 381.0% | 202.1% |
Return on equity (ROE) | -0.8% | -4.3% | 4.5% |
Change turnover | 18 | -7 | -6 |
Change turnover % | 23% | -8% | -6% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.